Latest DEF 14A proxy statements

Kearny Financial Corp. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, auditor ratification, and advisory executive compensation approval.

Federated Hermes Premier Municipal Income Fund has issued a proxy statement for its annual meeting on October 9, 2026, seeking shareholder approval for the election of several trustees.

Dror Ortho-Design, Inc. has scheduled a special meeting for September 23, 2026, to seek stockholder approval for a reverse stock split, with a ratio between 1-for-2 and 1-for-2,000.

Richtech Robotics Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director re-election and auditor ratification.

iPower Inc. has called a special meeting of stockholders to vote on proposals including a stock offering, reverse stock split, and equity incentive plan amendments.

Seagate Technology Holdings plc has announced its 2026 Annual General Meeting of Shareholders, scheduled for October 24, 2026, to address director elections, executive compensation, and other corporate matters.

Cayson Acquisition Corp is seeking shareholder approval to extend its deadline for completing a business combination, following the termination of a prior agreement, with provisions for insider loans and shareholder redemption rights.

CACI International Inc. has announced its 2026 Annual Meeting of Shareholders, scheduled for October 15, 2026, to be conducted virtually, with key agenda items including director elections, executive compensation advisory vote, and auditor ratification.

Grown Rogue International Inc. has announced its annual and special meeting of shareholders, scheduled for October 26, 2026, to address key corporate matters including director elections and a proposed share consolidation.

Kartoon Studios, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for October 21, 2026, to elect directors, ratify auditors, and seek approval to increase shares available under its 2020 Incentive Plan.

Jasper Therapeutics is holding a special meeting on September 30, 2026, to vote on a reverse stock split and an increase in authorized shares, primarily to regain Nasdaq compliance and facilitate future corporate needs.

Standex International Corporation has released its 2026 Proxy Statement, detailing director elections, executive compensation advisory vote, and auditor ratification, alongside comprehensive governance and ESG updates.

Taylor Devices, Inc. has issued its proxy statement for the 2026 Annual Meeting of Shareholders, detailing proposals for director election, auditor ratification, and executive compensation.

Paychex, Inc. announced its 2026 Annual Meeting of Stockholders, scheduled for October 15, 2026, detailing proposals including director elections, executive compensation, and auditor ratification, while also reporting strong fiscal 2026 business highlights.

Oxford Lane Capital Corp. has announced its 2026 Annual Meeting of Stockholders, scheduled for October 22, 2026, to elect a director and address other business.

TechPrecision Corporation announces its upcoming virtual Annual Meeting of Stockholders on September 29, 2026, detailing proposals including director elections, auditor ratification, executive compensation review, and an amended equity incentive plan.

Aptevo Therapeutics Inc. is holding a special meeting on September 22, 2026, to vote on critical proposals including charter amendments, stock and warrant issuances, and an updated stock incentive plan.

FingerMotion is holding a special meeting on October 6, 2026, to seek shareholder approval for issuing up to 19.99% of its stock to an institutional investor and increasing authorized shares.

GEE Group Inc. is convening its 2026 Annual Meeting of Shareholders virtually on September 24, 2026, to vote on key proposals including a 1-for-30 reverse stock split and a significant increase in authorized shares.

Spark I Acquisition Corporation is seeking shareholder approval to extend its deadline for completing a business combination with ZincFive, Inc. from September 29, 2026, to March 29, 2027.

Envoy Medical is holding a special meeting on October 12, 2026, to vote on a reverse stock split proposal aimed at regaining compliance with Nasdaq's minimum bid price requirement.

Catheter Precision, Inc. has issued a proxy statement detailing proposals for its upcoming Annual Meeting of Stockholders, including director elections, reincorporation, and equity plan amendments.

Bone Biologics Corporation has rescheduled its Annual Meeting of Stockholders to September 28, 2026, adding proposals for warrant share issuance approval and a reverse stock split.

NN, Inc. is holding a special meeting on September 30, 2026, to vote on several amendments to its Certificate of Incorporation, including a significant increase in authorized common stock.

Profusa, Inc. is holding a special meeting of stockholders on September 18, 2026, to vote on a proposal to approve an amendment to its Certificate of Incorporation to effect one or more reverse stock splits.

National Beverage Corp. has announced its Annual Meeting of Shareholders, scheduled for October 2, 2026, to elect a director and vote on executive compensation.

MillerKnoll announces its 2026 Annual Meeting of Shareholders, detailing proposals for director elections, executive compensation, and the 2026 Long-Term Incentive Plan, alongside fiscal 2026 financial highlights.

Immersion Corporation has announced its 2026 Annual Meeting of Stockholders, scheduled for October 7, 2026, to elect directors, ratify auditors, and vote on executive compensation.

Champions Oncology, Inc. has announced its Annual Meeting of Stockholders scheduled for October 14, 2026, with key proposals including the election of directors and the approval of the 2026 Equity Incentive Plan.

The Korea Fund, Inc. has issued its definitive proxy statement for the Annual Meeting of Stockholders on October 21, 2026, seeking shareholder approval for the re-election of Class II Director Matthew Sippel.